HESI RN
HESI RN 301 Pharmacology Final Exam Questions
Extract:
Question 1 of 5
A client receives a prescription for methotrexate. Which information provided by the client requires additional instruction by the nurse?
Correct Answer: B
Rationale: Methotrexate is teratogenic and contraindicated in pregnancy due to fetal harm risks. Weekly platelet counts monitor bone marrow suppression, folic acid mitigates side effects (though not specifically for liver protection), and room temperature storage is correct.
Question 2 of 5
A client receives a prescription for methotrexate. Which information provided by the client requires additional instruction by the nurse?
Correct Answer: B
Rationale: Methotrexate is teratogenic and contraindicated in pregnancy due to fetal harm risks. Weekly platelet counts monitor bone marrow suppression, folic acid mitigates side effects (though not specifically for liver protection), and room temperature storage is correct.
Question 3 of 5
A client with hepatic encephalopathy is receiving lactulose. Which assessment provides the nurse with the best information to evaluate the client's therapeutic response to the medication?
Correct Answer: D
Rationale: Lactulose reduces ammonia in hepatic encephalopathy, so monitoring serum ammonia and electrolytes (due to laxative effects) best evaluates response. Glucose, stool, and hepatic enzymes are less direct indicators.
Question 4 of 5
A client is scheduled for a spiral computed tomography (CT) scan with contrast to evaluate for pulmonary embolism. Which information in the client's history requires follow up by the nurse?
Correct Answer: A
Rationale: Metformin risks lactic acidosis with contrast dye, requiring follow-up to hold the drug and monitor renal function. Prostheses, sobriety, and prior scans are less critical.
Question 5 of 5
A client diagnosed with chronic obstructive pulmonary disease (COPD) is given a new prescription for tiotropium via an inhalation device. Which statement indicates that the client understands the instructions for using this medication?
Correct Answer: A
Rationale: Tiotropium is a daily maintenance inhaler for COPD. The client’s statement about daily use is correct. It doesn’t thin sputum, isn’t used with other inhalers between doses, and isn’t for acute shortness of breath.